跳至主要内容
临床试验/IRCT20170214032571N2
IRCT20170214032571N2已完成3 期

The effect of supplemental omega-3 and zinc supplementation on inflammation, lipid profiles and antioxidant capacity in type 2 diabetic patients

rmia University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • tendency to Cooperation
  • Type 2 diabetic patients ; taking metformin or glibenclamide glucose or similar drugs by patients
  • Age range 18 to 65 years
  • use of lipid lowering statin drugs and a blood pressure lowering drugs

排除标准

  • Unwillingness to participate in the study
  • Insulin injection
  • Do not consume 80% of supplements per course
  • People with pancreatic cancer and patients receiving steroidal anti-inflammatory drugs (due to secondary hyperglycemia)
  • severe physical activity
  • Use of omega-3 and zinc supplementation in the last three months
  • developing any underlying coronary artery disease and cancer
  • taking antidepressants (because of interactions with zinc supplementation)

研究者

发起方
rmia University of Medical Sciences

相似试验